Across all 44 tumours represented in the pTMA, accuracy (i.e. percentage of tumours that were correctly identified as having ‘high’ or ‘low’ true TIL burden) was 70.5% and 90.9% for CD3 and CD8 respectively. Here, CD8A is linked to neoplasm.